Ashvattha Therapeutics, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-17 | NCT07943221 Study Evaluating Safety & Tolerability of Migaldendranib in US Healthy Volunteers | Phase 1 | Active, Not Recruiting |
Active trials by phase
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 1 |
Disease areas by active trials
ALS (1) · Alzheimer's Disease (1) · Dementia (1) · Multiple Sclerosis (1) · Parkinson's Disease (1)
Get alerts when Ashvattha Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.